SE­CU­RITY CHECK

Ig­no­rance isn’t bliss when it comes to skin can­cer. Here’s what you need to know. By EM­I­LIE DINGFELD

Fashion (Canada) - - Skin -

Go­ing Vi­ral

In a phar­ma­ceu­ti­cal-spon­sored clin­i­cal trial, re­searchers at the Uni­ver­sity of Utah tested a new can­cer vac­cine made from the her­pes sim­plex virus in pa­tients with ad­vanced melanoma. Sixty-four per cent of tu­mours in­jected with it shrank, while 47 per cent dis­ap­peared com­pletely. It even helped re­duce or elim­i­nate tu­mours in other parts of the body. By in­ject­ing the can­cer cells with a virus, it’s thought that the im­mune sys­tem starts to fight th­ese cells as if they were in­vaders.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.